These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
946 related articles for article (PubMed ID: 1577926)
1. Sex hormones and cardiovascular risk. La Vecchia C Hum Reprod; 1992 Feb; 7(2):162-7. PubMed ID: 1577926 [TBL] [Abstract][Full Text] [Related]
2. Lipids and cardiovascular disease: do the findings and therapy apply equally to men and women? LaRosa JC Womens Health Issues; 1992; 2(2):102-11; discussion 111-3. PubMed ID: 1617306 [TBL] [Abstract][Full Text] [Related]
3. On the epidemiology of oral contraceptives and disease. Prentice RL; Thomas DB Adv Cancer Res; 1987; 49():285-401. PubMed ID: 3314396 [TBL] [Abstract][Full Text] [Related]
4. The metabolic impact of oral contraceptives. Krauss RM; Burkman RT Am J Obstet Gynecol; 1992 Oct; 167(4 Pt 2):1177-84. PubMed ID: 1415443 [TBL] [Abstract][Full Text] [Related]
5. Oral contraceptive and postmenopausal estrogen effects on lipoprotein triglyceride and cholesterol in an adult female population: relationships to estrogen and progestin potency. Knopp RH; Walden CE; Wahl PW; Hoover JJ; Warnick GR; Albers JJ; Ogilvie JT; Hazzard WR J Clin Endocrinol Metab; 1981 Dec; 53(6):1123-32. PubMed ID: 7298796 [TBL] [Abstract][Full Text] [Related]
6. The risk of breast cancer associated with oral contraception and hormone replacement therapy. Speroff L Womens Health Issues; 1992; 2(2):63-72; discussion 73-4. PubMed ID: 1535527 [TBL] [Abstract][Full Text] [Related]
8. Breast cancer in young women and use of oral contraceptives: possible modifying effect of formulation and age at use. Pike MC; Henderson BE; Krailo MD; Duke A; Roy S Lancet; 1983 Oct; 2(8356):926-30. PubMed ID: 6138501 [TBL] [Abstract][Full Text] [Related]
9. Exogenous progestins and breast cancer. Stanford JL; Thomas DB Epidemiol Rev; 1993; 15(1):98-107. PubMed ID: 8405216 [TBL] [Abstract][Full Text] [Related]
10. Cancer of the breast and reproductive tract in relation to use of oral contraceptives. Schlesselman JJ Contraception; 1989 Jul; 40(1):1-38. PubMed ID: 2673658 [TBL] [Abstract][Full Text] [Related]
12. Latest views on pill prescribing. Kay CR J R Coll Gen Pract; 1984 Nov; 34(268):611-4. PubMed ID: 6502571 [TBL] [Abstract][Full Text] [Related]
13. Sex hormones and coronary disease: a review of the clinical studies. Kalin MF; Zumoff B Steroids; 1990 Aug; 55(8):330-52. PubMed ID: 2237942 [TBL] [Abstract][Full Text] [Related]
14. Absence of correlation between oral contraceptive usage and cardiovascular mortality. Wiseman RA Int J Fertil; 1984; 29(4):198-208. PubMed ID: 6152441 [TBL] [Abstract][Full Text] [Related]
15. Estimates of the risk of cardiovascular death attributable to low-dose oral contraceptives in the United States. Schwingl PJ; Ory HW; Visness CM Am J Obstet Gynecol; 1999 Jan; 180(1 Pt 1):241-9. PubMed ID: 9914611 [TBL] [Abstract][Full Text] [Related]
16. Cancer risks and the contraceptive pill. What is the evidence after nearly 25 years of use? Khoo SK Med J Aust; 1986 Feb; 144(4):185-90. PubMed ID: 3511357 [TBL] [Abstract][Full Text] [Related]
17. Reassessment of the metabolic effects of oral contraceptives. Franklin M J Nurse Midwifery; 1990; 35(6):358-64. PubMed ID: 2286849 [TBL] [Abstract][Full Text] [Related]
18. Oral contraceptives and breast cancer. Brinton LA; Hoover R; Szklo M; Fraumeni JF Int J Epidemiol; 1982 Dec; 11(4):316-22. PubMed ID: 7152784 [TBL] [Abstract][Full Text] [Related]